Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidar Staalesen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Genetic and epigenetic changes in p21 and p21B do not correlate with resistance to doxorubicin or mitomycin and 5-fluorouracil in locally advanced breast cancerVidar Staalesen, Beryl Leirvaag, Johan Richard Lillehaug, et al.
Journal of Obesity|March 16, 2011
Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agentsBodil Bjørndal, Lena Burri, Vidar Staalesen, et al.
Journal of Obesity|January 29, 2011
Tissue-specific effects of bariatric surgery including mitochondrial functionSimon N Dankel, Vidar Staalesen, Bodil Bjørndal, et al.
Biochimica Et Biophysica Acta|January 19, 2010
Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activityElisabet Ognedal Berge, Vidar Staalesen, Anne Hege Straume, et al.
International Journal of Cancer|April 20, 2007
Mutations and polymorphisms of the p21B transcript in breast cancerStian Knappskog, Ranjan Chrisanthar, Vidar Staalesen, et al.
Oncogene|September 14, 2004
Alternative splicing and mutation status of CHEK2 in stage III breast cancerVidar Staalesen, Jacob Falck, Stephanie Geisler, et al.
Molecular Cancer|July 3, 2010
Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancersElisabet Ognedal Berge, Stian Knappskog, Stephanie Geisler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
The novel p21 polymorphism p21G251A is associated with locally advanced breast cancerVidar Staalesen, Stian Knappskog, Ranjan Chrisanthar, et al.
Molecular Oncology|May 26, 2015
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivoStian Knappskog, Elisabet O Berge, Ranjan Chrisanthar, et al.
Cancer Cell|February 15, 2011
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in CaucasiansStian Knappskog, Merete Bjørnslett, Line M Myklebust, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Genetic and epigenetic changes in p21 and p21B do not correlate with resistance to doxorubicin or mitomycin and 5-fluorouracil in locally advanced breast cancerVidar Staalesen, Beryl Leirvaag, Johan Richard Lillehaug, et al.
Journal of Obesity|March 16, 2011
Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agentsBodil Bjørndal, Lena Burri, Vidar Staalesen, et al.
Journal of Obesity|January 29, 2011
Tissue-specific effects of bariatric surgery including mitochondrial functionSimon N Dankel, Vidar Staalesen, Bodil Bjørndal, et al.
Biochimica Et Biophysica Acta|January 19, 2010
Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activityElisabet Ognedal Berge, Vidar Staalesen, Anne Hege Straume, et al.
International Journal of Cancer|April 20, 2007
Mutations and polymorphisms of the p21B transcript in breast cancerStian Knappskog, Ranjan Chrisanthar, Vidar Staalesen, et al.
Oncogene|September 14, 2004
Alternative splicing and mutation status of CHEK2 in stage III breast cancerVidar Staalesen, Jacob Falck, Stephanie Geisler, et al.
Molecular Cancer|July 3, 2010
Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancersElisabet Ognedal Berge, Stian Knappskog, Stephanie Geisler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
The novel p21 polymorphism p21G251A is associated with locally advanced breast cancerVidar Staalesen, Stian Knappskog, Ranjan Chrisanthar, et al.
Molecular Oncology|May 26, 2015
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivoStian Knappskog, Elisabet O Berge, Ranjan Chrisanthar, et al.
Cancer Cell|February 15, 2011
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in CaucasiansStian Knappskog, Merete Bjørnslett, Line M Myklebust, et al.
Pageof 1